We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Cardiology
 1821-1840 of 2396 Articles
Clinical Cardiology |  FREE
Graham C. Wong, MD; Robert P. Giugliano, MD, SM; Elliott M. Antman, MD
JAMA. 2003;289(3):331-342. doi:10.1001/jama.289.3.331.

Health Agencies Update | 
Brian Vastag
JAMA. 2003;289(3):290. doi:10.1001/jama.289.3.290-a.

Medical News and Perspectives | 
Mike Mitka
JAMA. 2003;289(3):288-289. doi:10.1001/jama.289.3.288.

Original Contribution |  FREE
Margaret M. Redfield, MD; Steven J. Jacobsen, MD, PhD; John C. Burnett, Jr, MD; et al.
JAMA. 2003;289(2):194-202. doi:10.1001/jama.289.2.194.

Editorial | 
David A. Kass, MD
JAMA. 2002;288(24):3159-3161. doi:10.1001/jama.288.24.3159.

Editorial | 
Judith S. Hochman, MD; Jacqueline E. Tamis-Holland, MD
JAMA. 2002;288(24):3161-3164. doi:10.1001/jama.288.24.3161.

Original Contribution |  FREE
Ruchira Glaser, MD; Howard C. Herrmann, MD; Sabina A. Murphy, MPH; et al.
JAMA. 2002;288(24):3124-3129. doi:10.1001/jama.288.24.3124.

Original Contribution |  FREE
The DAVID Trial Investigators*
JAMA. 2002;288(24):3115-3123. doi:10.1001/jama.288.24.3115.

JAMA Patient Page |  FREE
JAMA. 2002;288(24):3230. doi:10.1001/jama.288.24.3230.

Commentary | 
Myron L. Weisfeldt, MD; Lance B. Becker, MD
JAMA. 2002;288(23):3035-3038. doi:10.1001/jama.288.23.3035.

Editorial | 
Richard C. Pasternak, MD
JAMA. 2002;288(23):3042-3044. doi:10.1001/jama.288.23.3042.

Editorial | 
Lawrence J. Appel, MD, MPH
JAMA. 2002;288(23):3039-3042. doi:10.1001/jama.288.23.3039.

Original Contribution |  FREE
Leonard A. Cobb, MD; Carol E. Fahrenbruch, MSPH; Michele Olsufka, RN; et al.
JAMA. 2002;288(23):3008-3013. doi:10.1001/jama.288.23.3008.

Original Contribution |  FREE
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
JAMA. 2002;288(23):2981-2997. doi:10.1001/jama.288.23.2981.

Original Contribution |  FREE
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
JAMA. 2002;288(23):2998-3007. doi:10.1001/jama.288.23.2998.

Medical News & Perspectives | 
Sarah Pressman Lovinger, MD
JAMA. 2002;288(23):2952. doi:10.1001/jama.288.23.2952-JMN1218-2-1.

Medical News & Perspectives | 
JAMA. 2002;288(22):2812. doi:10.1001/jama.288.22.2812-JMN1211-2-2.

Original Contribution |  FREE
Hanna-Maaria Lakka, MD, PhD; David E. Laaksonen, MD, MPH; Timo A. Lakka, MD, PhD; et al.
JAMA. 2002;288(21):2709-2716. doi:10.1001/jama.288.21.2709.

Editorial | 
Raymond J. Gibbons, MD
JAMA. 2002;288(21):2745-2746. doi:10.1001/jama.288.21.2745.

Original Contribution |  FREE
James E. Udelson, MD; Joni R. Beshansky, RN, MPH; Daniel S. Ballin, MD; et al.
JAMA. 2002;288(21):2693-2700. doi:10.1001/jama.288.21.2693.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Internal Medicine
Invited Commentary  | 
New Approaches to Reduce Readmissions in Patients With Heart Failure
Kumar Dharmarajan, MD, MBA; Sarwat I. Chaudhry, MD
JAMA Internal Medicine
Original Investigation  | 
Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure The Better Effectiveness After Transition–Heart Failure (BEAT-HF) Randomized Clinical Trial
Michael K. Ong, MD, PhD; Patrick S. Romano, MD, MPH; Sarah Edgington, MA; et al.
JAMA Internal Medicine
Teachable Moment  | 
Pseudoatrial Flutter Waves—When a Flutter Is Not a Flutter
Nathanial S. Nolan, BS; Scott M. Koerber, DO; Sudarshan Balla, MD
JAMA Oncology
Original Investigation  | 
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival A Systematic Review and Meta-analysis
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.